Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 23, 2026 09:53 ET | Source: Phlow Corp.

Phlow Applauds New U.S. Government Investment in Advancing America's Domestic Medicine Supply Chain

RICHMOND, Va., July 23, 2026 (GLOBE NEWSWIRE) -- Phlow Corp., a U.S.-based advanced pharmaceutical contract development and manufacturing organization (CDMO) dedicated to strengthening the nation's...
July 22, 2026 09:00 ET | Source: Alira Health

Specialized Manufacturing Capability Emerges as the New Competitive Advantage in the $23.2 Billion Global Biologics CDMO Market, Finds Alira Health

Alira Health today released the 2026 Biologics Contract Manufacturing Report, its annual analysis of the global CDMO market.
July 15, 2026 04:10 ET | Source: Research and Markets

Oligonucleotide CDMO Market to Reach USD 9.87 Billion by 2031 as RNA-Targeted Drug Pipelines Expand

Dublin, July 15, 2026 (GLOBE NEWSWIRE) -- The "Oligonucleotide CDMO - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been added to ...
July 07, 2026 10:00 ET | Source: PDV MedTech Inc.; Corscience

PDV MedTech and Corscience Announce Strategic Partnership to Advance MedTech Development and Manufacturing Across the US and Europe

PDV MedTech and Corscience announce a strategic partnership to advance medtech development and manufacturing in the U.S. and Europe.
July 06, 2026 00:30 ET | Source: Custom Market Insights

[Latest] Global Beadlets Capsule Market Size/Share Worth USD 968.45 Million by 2035 at a 6.85% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, July 06, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Beadlets Capsule Market Size, Trends and Insights By Type (Vitamin Beadlets,...
June 30, 2026 12:00 ET | Source: AGC Biologics, Inc.

AGC Biologics Expands to Fill-Finish in U.S. Through Strategic Partnership with Pyramid Pharma Services

Drug developers have a new, optimized option for U.S.-based manufacturing, as AGC Biologics enters a strategic partnership with Pyramid Pharma Services.
June 30, 2026 05:36 ET | Source: Intravacc B.V.

Intravacc Makes Qualified Vero Cell Banks Available to Accelerate Viral Vaccine Development

Intravacc Makes Qualified Vero Cell Banks Available to Accelerate Viral Vaccine Development
June 30, 2026 05:32 ET | Source: Intravacc B.V.

Intravacc Highlights Four Integrated Vaccine Development Platforms for CDMO Partners

Intravacc Highlights Four Integrated Vaccine Development Platforms for CDMO Partners
June 23, 2026 09:03 ET | Source: SK pharmteco Inc.

SK pharmteco Announces SKyvec™, A Unified, High-Yield Viral Vector Platform Designed to Accelerate Gene Therapy Development from Batch to Bedside

SK pharmteco today announced the launch of SKyvec™, its proprietary, multimodal viral vector platform.
June 18, 2026 10:30 ET | Source: MarketsandMarkets Research Pvt. Ltd.

Oligonucleotide CDMO Market Expected to Reach USD 6.73 Billion by 2029 | MarketsandMarkets™

Delray Beach, FL, June 18, 2026 (GLOBE NEWSWIRE) -- The global oligonucleotide CDMO market is projected to grow from USD 2.51 billion in 2024 to USD 6.73 billion by 2029, registering a CAGR of 21.8%...